Align Technology vs West Pharmaceutical Services
Align Technology is the larger business, with $4.03bn of revenue in fiscal 2025 against $3.07bn for West Pharmaceutical Services (1.3 times as much). West Pharmaceutical Services grew faster (6.3% against 0.9%). West Pharmaceutical Services kept more of each dollar of sales as profit: a net margin of 16.1% against 10.2%. Align Technology carries less debt relative to equity (0.0% against 6.4%).
| Latest fiscal year | Align TechnologyALGN, 2025 | West Pharmaceutical ServicesWST, 2025 |
|---|---|---|
| Revenue | $4.03bn | $3.07bn |
| Revenue growth | 0.9% | 6.3% |
| Net income | $410m | $494m |
| Operating margin | 13.5% | 19.0% |
| Net margin | 10.2% | 16.1% |
| Return on equity | 10.4% | 16.9% |
| Free cash flow | $491m | $469m |
| Cash | $1.09bn | $791m |
| Total debt | $0 | $203m |
| Debt to equity | 0.0% | 6.4% |
| Dividend per share | — | $0.86 |
| Dividend yield | — | 0.2% |
| Share buybacks | $466m | $134m |
| Employees | 20,290 | — |
| Market value | $10.77bn | $28.63bn |
| Price vs our value range | Above our value range | Above our value range |
| Moat score | 85 (Strong) | 77 (Strong) |
| Insider trades, 12 months | 0 buys, 1 sales | 0 buys, 8 sales |